(Commercial Product) Solution for Injection
2.5 mg / 0.5 mL | 5 mg / 0.5 mL | 7.5 mg / 0.5 mL | 10 mg / 0.5 mL | 12.5 mg / 0.5 mL | 15 mg / 0.5 mL
Product Overview Coming Soon
Product Overview
Tirzepatide Description 1-4
Tirzepatide is a novel dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is administered as a once-weekly subcutaneous injection and is indicated for use alongside a reduced-calorie diet and increased physical activity to support reduction of excess body weight and the long-term maintenance of weight reduction in adults with obesity or who are overweight.
References
Mechanism of Action1-3
Tirzepatide exerts its effects through dual incretin receptor agonism, targeting both:
Adverse Reactions1-4
Most adverse reactions are gastrointestinal in nature and dose-dependent:
Contraindications & Precautions1-4
Contraindications:
Precautions:
Store refrigerated at 36°F to 46°F (2°C – 8°C). Discard within 28 days of puncture or according to the beyond-use date. Do not freeze. Keep out of reach of children.
EXPLORE MORE
Related Medications
Licensed to ship across the U.S.
Your orders arrive promptly and privately, delivered directly to your door.
Providers: Let’s Partner for Better Patient Care
If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.
To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com
New providers setup / update an existing account:
newaccounts@wppharmalabs.com
